6 months ago, after all other treatments for T-cell acute lymphoblastic leukaemia had failed, 13-year-old Alyssa became the first person in the world to receive base-edited cell therapy as part of a clinical trial at GOSH, in collaboration with University College London.
Watch to meet Alyssa and the research team behind the trial.
To learn more about this research breakthrough, visit our website:
www.gosh.nhs.uk/news/gosh-pat...
20 дек 2022
